Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors
Clinical trial NCT03043664 · COMPLETED
Trial details
- NCT number
- NCT03043664
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2021-05-03
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.